SCHEMBL30910883

SCHEMBL30910883

CC(Cl)c1ccc(C2CC2)cc1F

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IDH1 O75874 1/20 0.37
▸ PTGS1 P23219 2/20 0.35
▸ PTGS2 P35354 2/20 0.35
▸ DGKA P23743 3/20 0.33
▸ DGKZ Q13574 3/20 0.33
▸ CXCR3 P49682 1/20 0.33
▸ APP P05067 1/20 0.33
▸ GRIA4 P48058 1/20 0.32
▸ PDE2A O00408 2/20 0.32
▸ SCN1A P35498 1/20 0.32
▸ SCN5A Q14524 1/20 0.32
▸ SCN8A Q9UQD0 1/20 0.32
▸ MGLL Q99685 1/20 0.32
▸ MCOLN2 Q8IZK6 1/20 0.32
▸ TLR9 Q9NR96 1/20 0.32
▸ TLR8 Q9NR97 1/20 0.32
▸ TLR7 Q9NYK1 1/20 0.32
▸ ESR2 Q92731 1/20 0.32
▸ ADRB2 P07550 1/20 0.31
▸ HSD11B1 P28845 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21831890 1.00 IDH1 (0.37) IDH1PTGS1PTGS2DGKADGKZ
SCHEMBL15028921 0.85 MGLL (0.40) IDH1PTGS1PTGS2DGKADGKZ
SCHEMBL18097789 0.82 PDE2A (0.38) IDH1PTGS1PTGS2DGKADGKZ
SCHEMBL30910925 0.82 PDE2A (0.38) IDH1PTGS1PTGS2DGKADGKZ
SCHEMBL18097826 0.82 IDH1 (0.37) IDH1PTGS1PTGS2DGKADGKZ
SCHEMBL31064692 0.79 IDH1 (0.43) IDH1PTGS1PTGS2DGKADGKZ
SCHEMBL13499049 0.79 APP (0.41) IDH1PTGS1PTGS2APPGRIA4
SCHEMBL29611795 0.78 ESR2 (0.44) IDH1PTGS1PTGS2APPPDE2A
SCHEMBL26923110 0.78 ESR2 (0.44) IDH1PTGS1PTGS2APPPDE2A
SCHEMBL21872202 0.77 APP (0.43) PTGS1PTGS2APPMGLL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112654621-B Substituted naphthyridinone compounds useful as T cell activators 百时美施贵宝公司 2024-05-14 — — CN disclosed
Send feedback